ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA Approves Inrebic (fedratinib) for the Treatment of Patients With Myelofibrosis
August 19, 2019Celgene Corporation announced the U.S. Food and Drug Administration (FDA) has approved Inrebic (fedratinib) for the treatment of adult patients with intermediate-2 or high-risk primary or ... -
Celgene’s fedratinib gets FDA priority review for myelofibrosis
March 08, 2019Celgene has secured the US Food and Drug Administration (FDA) priority review status for the new drug application (NDA) of fedratinib to treat patients with myelofibrosis.
Pharma Sources Insight January 2025
